Results 1 to 10 of about 3,249,142 (188)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. [PDF]

BMC Psychiatry, 2023
Background Escitalopram is selective serotonin reuptake inhibitors (SSRIs) and one of the most commonly prescribed newer antidepressants (ADs) worldwide.
Yin J, Song X, Wang C, Lin X, Miao M.
europepmc   +4 more sources

The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis. [PDF]

Int J Environ Res Public Health, 2018
Antidepressive agents are one of the fastest-growing classes of prescribed drugs. However, the effects of antidepressive agents on bone density are controversial.
Schweiger JU, Schweiger U, Hüppe M, Kahl KG, Greggersen W, Jauch-Chara K, Fassbinder E.   +6 more
europepmc   +4 more sources

A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia. [PDF]

Intern Med, 2017
Objective Functional dyspepsia (FD) is defined as persistent or recurrent pain or discomfort centered in the upper abdomen without organic disease. Psychosocial factors have been proposed as an important element in the pathophysiology of FD.
Hojo M, Nagahara A, Asaoka D, Shimada Y, Sasaki H, Matsumoto K, Takeda T, Ueyama H, Matsumoto K, Watanabe S.   +9 more
europepmc   +4 more sources

Evaluating the effects of physical activity and antidepressive agents on depressive symptoms in older adults: a meta-analysis of existing evidence. [PDF]

BMC Geriatr
Although a wide range of treatments for depression are currently available, the condition continues to pose a substantial threat to the physical health of older adults.
Zhang S, Miao C.
europepmc   +5 more sources

Advancing Antidepressive Agents: Drug Discovery and Polymer-Based Drug Delivery Systems for Improved Treatment Outcome. [PDF]

Biomedicines
Depressive disorder (a subclass of mental disorders) is characterized by persistent affective symptoms. Without timely therapeutic intervention, it leads to clinical deterioration manifested as reduced quality of life and may increase suicide risk in ...
Zhang Y, Song Z, Zhang H, Lin H, Xu P, Li Z, He Q, Wei B.   +7 more
europepmc   +4 more sources

Sertraline versus other antidepressive agents for depression. [PDF]

Cochrane Database Syst Rev, 2010
Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.   +7 more
europepmc   +5 more sources

Agomelatine versus other antidepressive agents for major depression. [PDF]

Cochrane Database Syst Rev, 2013
Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M.   +5 more
europepmc   +4 more sources

Reboxetine versus other antidepressive agents for depression [PDF]

Cochrane Database Syst Rev, 2018
Churchill R, Caldwell D, McGuire H, Barbui C, Cipriani A, Furukawa T, Watanabe N, Lewis G.   +7 more
europepmc   +4 more sources

Milnacipran versus other antidepressive agents for depression. [PDF]

Cochrane Database Syst Rev, 2009
Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA.   +7 more
europepmc   +3 more sources

Mirtazapine versus other antidepressive agents for depression. [PDF]

Cochrane Database Syst Rev, 2011
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, Furukawa TA.   +6 more
europepmc   +3 more sources